IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

SEC filing

IOVANCE BIOTHERAPEUTICS, INC.

IOVA · CIK 1425205

4 · Sep 10, 2026 · Director, Interim CEO & General Counsel Vogt Frederick G exercised options for 15.63K shares; reported 6,638 shares

Director, Interim CEO & General Counsel Vogt Frederick G exercised options for 15.63K shares; reported 6,638 shares

OWNERSHIP DOCUMENT

xslF345X06/tm2625111-3_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).